US Patent Issued to Seaport Therapeutics, Monash University on April 7 for "Lipid prodrugs of JAK inhibitors and uses thereof" (Australian, American Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,339, issued on April 7, was assigned to Seaport Therapeutics Inc. (Seaport Boston, Mass.) and Monash University (Victoria, Australia).

"Lipid prodrugs of JAK inhibitors and uses thereof" was invented by Joseph Bolen (Wayland, Mass.), Daniel Kenneth Bonner (Sharon, Mass.), Ketki Karanam (Newton, Mass.), Christopher John Porter (South Melbourne, Australia), Jamie Simpson (Chestnut Hill, Mass.), Natalie Trevaskis (Newington, Australia), Dan Zheng (Clayton, Australia), Nathania Leong (Clayton, Australia), Garima Sharma (Clayton, Australia), Mitchell McInerney (Clayton, Australia), Tim Quach (Boston) and Sifei Han (Bundoora, Australia).

According to the abstract* released by the U.S. ...